Clinical Trials
13 trialsNCT07591571 2026-05-15
To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC
Loma Linda University
Phase NA Recruiting
NCT05006131 2026-04-23
PancreasScan
Beth Israel Deaconess Medical Center
Recruiting
NCT07529626 2026-04-14
MIND-PANC
Shanghai Zhongshan Hospital
Not yet recruiting
NCT07478185 2026-04-03
Prehab for Pancreatic Cancer Surgery
University of Massachusetts, Worcester
Phase NA Recruiting
NCT06803771 2026-03-23
SAFE-D
University Hospital Southampton NHS Foundation Trust
Phase NA Recruiting
NCT07436741 2026-02-27
Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Not yet recruiting
NCT03977233 2026-01-13
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Recruiting
NCT06717295 2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
NCT06388967 2025-12-19
PCDC
City of Hope Medical Center
Recruiting
NCT07277452 2025-12-11
NOTABLE-309
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT06584227 2025-12-08
ACPC
Jinling Hospital, China
Phase 2 Recruiting
NCT03854110 2025-09-11
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine
Geistlich Pharma AG
Phase 1 Active not recruiting
NCT06852014 2025-09-02
Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Phase NA Recruiting